Atrial Fibrillation History Feature vs Cleerly LABS
AI Verdict
Choose Atrial Fibrillation History Feature if…
Choose the Apple Atrial Fibrillation History Feature if you are a diagnosed AFib patient seeking to understand the long-term patterns of your condition and how lifestyle choices impact its frequency. This tool is ideal for gaining retrospective insights into your AFib burden over time and sharing a clear summary of this data with your healthcare provider to inform treatment discussions.
View Atrial Fibrillation History Feature →Choose Cleerly LABS if…
Choose Cleerly LABS if you require a detailed, AI-powered analysis of coronary CT angiography (CCTA) to precisely detect, quantify, and characterize atherosclerosis and stenosis. This tool is best suited for clinicians and patients who need an in-depth understanding of coronary plaque burden and its progression, enabling personalized heart disease management and risk assessment.
View Cleerly LABS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Atrial Fibrillation History Feature | Cleerly LABS |
|---|---|---|
| Pricing | Unknown | Per analysis |
| Deployment | Mobile App | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. |
| BAA Available | No AI-estimated | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | No AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Atrial Fibrillation History FeatureTool A (Apple AFib History) is integrated into the familiar Apple ecosystem (Apple Watch and Health app), making it highly accessible and intuitive for general consumers. Tool B (Cleerly LABS) is a specialized web-based application designed for trained medical professionals, requiring specific clinical workflows and expertise.
Clinical Value
Cleerly LABSTool B (Cleerly LABS) provides comprehensive, AI-powered analysis of CCTA scans to detect, quantify, and characterize atherosclerosis and stenosis, directly aiding in diagnosis, risk stratification, and personalized heart disease management for clinicians. Tool A offers retrospective AFib burden estimates and lifestyle insights for already diagnosed patients, which is valuable for self-management and physician discussions but less foundational to direct clinical decision-making.
Pricing & Value
Atrial Fibrillation History FeatureTool A (Apple AFib History) is included with the purchase of a compatible Apple Watch, offering significant value to existing users at no additional cost. Tool B (Cleerly LABS) is a high-cost service, priced per analysis, often resulting in substantial out-of-pocket expenses for patients in addition to the CCTA scan cost.
Enterprise Readiness
Cleerly LABSTool B (Cleerly LABS) is explicitly designed for enterprise integration, featuring HIPAA compliance, BAA availability, and deployment as a cloud-based web application with integration capabilities for PACS, RIS, and EHR systems. Tool A is a consumer-facing feature and lacks the direct enterprise-level compliance and integration features required for healthcare systems.
Innovation
Cleerly LABSTool B (Cleerly LABS) demonstrates greater innovation by utilizing advanced AI for comprehensive, quantitative analysis of CCTA images to characterize plaque and stenosis, aiming to establish a new standard of care in cardiovascular imaging. Tool A, while a valuable application, leverages existing wearable technology for retrospective AFib tracking, which is less of a technological leap in core AI methodology.
Support & Docs
TieBoth tools offer appropriate support and documentation for their respective target audiences. Apple provides extensive consumer-facing support and user guides for its AFib History feature. Cleerly offers dedicated customer success and clinical support for healthcare professionals, including training and implementation assistance.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Atrial Fibrillation History Feature | Cleerly LABS |
|---|---|---|
| Primary Function | Provides diagnosed users with retrospective estimates of AFib burden and insights into how lifestyle factors may influence their condition, with data exportable for physician review. | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. |
| Company | Apple | Cleerly |
| Target Medical Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology, Radiology |
| Core Analysis/Output | Retrospective AFib burden estimation (weekly percentage), tracking and trending AFib burden over time. | Comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with Cleerly ISCHEMIA module). |
| Data Sharing/Visualization | PDF export of AFib History data for sharing with healthcare providers, visualization of lifestyle factors impacting AFib. | 3D visualization of coronary arteries, personalized heart disease risk assessment, tracking disease progression over time, integration with PACS, RIS, EHR via Cleerly Proxy. |
Videos
Demos, reviews, and walkthroughs featuring Atrial Fibrillation History Feature and Cleerly LABS.
Frequently Asked Questions
More Comparisons
More matchups featuring Atrial Fibrillation History Feature or Cleerly LABS
Backers
Who funded each tool's parent company.